Integrated Cannabis Solutions to purchase 200-acre farm in Wisconsin

capable of producing over $50 million a year in revenue

- The 20-acre test grow will cover the cost of the purchase

- Plenty of acreage to build green houses for seedlings

- CBD processing lab to be built on the property

Coconut Creek, FL -- December 12, 2018 -- InvestorsHub NewsWire -- Integrated Cannabis Solutions, Inc., (OTCPINK: IGPK) has agreed to purchase the 200 acre farm the test grow is being planted on, after a successful harvest of the 20 acres. The purchase of the farm will give Integrated a solid real estate Asset on the books.

The parties have agreed on a purchase price of $1,500,000 for the property that includes 3 sections of tillable land totaling 160 acres. The back history on the farm has proven both hemp and tobacco have been successfully planted on this farm. The soil is so rich in nutrients the crops require very little water. The farm has its own brook and water rights with pumping stations.

The test harvest will generate more than enough money to cover the cost of the purchase of the farm and fund the future operations on the farm. The initial harvest should yield $6-$8 million fully funding the farms next harvest of 160 acres and building a first class CBD lab.

The property already has a 3,000 square foot storage barn with a cement slab and an additional slab next to the barn to build another building, that will house a CBD lab to turn the plants into CBD Isolate.

The main issue farmers in Wisconsin have about growing hemp is the lack of places to process the crops in Wisconsin, this is why in 2018 far less people actually planted crops then where granted liceses.

On the additional 40 acres of land Green Houses will be built to house the seedlings for each planting, if timed right 2 planting per year could be done further increasing the revenue of the farm.

With the Farm Bill looking to be signed into law Integrated Cannabis is positioned to be a leader in Wisconsin by having the ability to both store and process industrial hemp into CBD Isolate.

Integrated Cannabis has been reviewing other opportunities within the Cannabis sector and will begin to give further updates shortly.

Integrated Cannabis Solutions, in compliance with SEC regulations, may in the future use social media outlets like Facebook or Twitter and its own website to announce key information in compliance with Reg FD.

Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, estimates of services and equipment markets, release of corporate apps, growth of platform, target markets, product releases, product demand and, business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also consider that any investment in securities is at risk.



Details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure on otcmarkets.com .

For additional information about this release please contact:



Investor Relations:

954-906-0098